Proglumide
As of the edition of 20 October 2026, Proglumide is a small molecule: withdrawn from the market in 1989; acts on CCKAR and CCKBR.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Withdrawn from market, 1989
- Kind
- Small molecule
- Withdrawn from market
- 1 January 1989 (in some regions)
- Registered trials
- 5, 1 stopped early
- Disease areas
- Digestive system; Hormones; Cancer; Nutrition and metabolism
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 3 | 2 | 0 | 1 |
| Phase 2 | 2 | 0 | 2 | 0 |
| All trials | 5 |